Valuation: OneSource Specialty Pharma Limited

Market Cap 18TCr 196.96Cr 178.93Cr 165.33Cr 149.33Cr 281.82Cr 291.73Cr 1.99TCr 787.77Cr 9.92TCr 739.06Cr 723.42Cr 31TCr P/E 2027 *
40.5x
P/E 2028 * 21.6x
Enterprise Value 19TCr 206.39Cr 187.5Cr 173.24Cr 156.49Cr 295.32Cr 305.7Cr 2.08TCr 825.49Cr 10TCr 774.45Cr 758.06Cr 33TCr EV / Sales 2027 *
8.21x
EV / Sales 2028 * 5.42x
Free-Float
64.51%
Yield 2027 *
-
Yield 2028 * -
1 day+0.16%
1 week-1.22%
Current month+3.18%
1 month+12.52%
3 months+3.43%
6 months-12.10%
Current year-10.93%
1 week 1,576.5
Extreme 1576.5
1,688
1 month 1,320.6
Extreme 1320.6
1,688
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,917.8
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2024
Director of Finance/CFO - 04/07/2024
Compliance Officer - 14/03/2023
Director TitleAgeSince
Chairman 65 22/09/2025
Director/Board Member 54 01/03/2024
Director/Board Member 66 27/02/2025
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%-1.22%-6.89% - 195.82Cr
-1.29%-1.76%+51.98%+64.66% 6.63TCr
-0.09%+7.58%+12.54%+93.05% 6.06TCr
+0.63%+1.64%+24.25%+89.70% 5.55TCr
-1.26%-1.45%+9.20%+117.42% 4.76TCr
-0.15%-5.06%+22.49%+29.27% 4.37TCr
-3.15%-16.63%+141.35%+685.27% 3.73TCr
+0.23%+1.66%+14.85%+49.06% 3.66TCr
+2.35%-3.61%+78.64%+60.70% 3.22TCr
+1.42%+5.84%-37.75%+402.78% 2.66TCr
Average -0.09%+0.36%+31.07%+176.88% 4TCr
Weighted average by Cap. -0.27%+0.33%+35.03%+152.00%

Financials

2027 *2028 *
Net sales 2.36TCr 25Cr 23Cr 21Cr 19Cr 36Cr 37Cr 253.77Cr 100.55Cr 1.27TCr 94Cr 92Cr 4.01TCr 3.44TCr 37Cr 33Cr 31Cr 28Cr 52Cr 54Cr 369.4Cr 146.37Cr 1.84TCr 137.32Cr 134.41Cr 5.84TCr
Net income 434.72Cr 4.63Cr 4.21Cr 3.89Cr 3.51Cr 6.62Cr 6.86Cr 47Cr 19Cr 233.29Cr 17Cr 17Cr 738.96Cr 882.9Cr 9.4Cr 8.54Cr 7.89Cr 7.13Cr 13Cr 14Cr 95Cr 38Cr 473.8Cr 35Cr 35Cr 1.5TCr
Net Debt 885.6Cr 9.43Cr 8.57Cr 7.92Cr 7.15Cr 13Cr 14Cr 95Cr 38Cr 475.25Cr 35Cr 35Cr 1.51TCr 116.4Cr 1.24Cr 1.13Cr 1.04Cr 93.99L 1.77Cr 1.84Cr 13Cr 4.96Cr 62Cr 4.65Cr 4.55Cr 197.86Cr
Projected Income Statement - Annual - OneSource Specialty Pharma Limited
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based Contract Development and Manufacturing Organization (CDMO). The Company offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply. The Company focuses on the development and manufacturing of complex pharmaceutical products including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatine capsules). It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. Its integrated services offer comprehensive biologics solutions. The Company develops a variety of soft gelatin capsules including traditional and enteric softgels, vegan capsule alternatives, chewable formats and specialty dosage forms, and liposomal systems and applicaps. It also provides end-to-end development and manufacturing of sterile injectable products.
Employees
1,674
Date Price Change Volume
16/26/16 ₹1,612.70 +0.16% 3,11,345
13/26/13 ₹1,610.10 -0.61% 5,99,203
12/26/12 ₹1,620.00 +2.42% 2,77,501
11/26/11 ₹1,581.70 -2.24% 2,21,763
09/26/09 ₹1,618.00 -0.89% 1,65,587
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - OneSource Specialty Pharma Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,612.70INR
Average target price
2,078.25INR
Spread / Average Target
+28.87%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OneSource Specialty Pharma Limited
  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock